UBS O'Connor’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-271,161
Closed -$1.95M 689
2023
Q1
$1.95M Buy
271,161
+6,912
+3% +$53.6K 0.05% 317
2022
Q4
$2.17M Buy
264,249
+24,881
+10% +$232K 0.04% 448
2022
Q3
$2.53M Sell
239,368
-60,000
-20% -$638K 0.03% 493
2022
Q2
$2.77M Buy
299,368
+124,368
+71% +$1.02M 0.03% 486
2022
Q1
$1.2M Buy
+175,000
New +$1.13M 0.01% 670

Other funds holding BLU

UBS O'Connor's BLU Position: Q2 2023 in Review

UBS O'Connor sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 271,161 shares — an estimated $1.95M sold.

UBS O'Connor first reported a position in BLU in Q1 2022 and held it in 5 quarters. The position peaked at $2.77M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • UBS O'Connor reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • UBS O'Connor sold 271,161 BELLUS Health Inc. shares in Q2 2023, an estimated $1.95M.
  • UBS O'Connor first reported a position in BELLUS Health Inc. in Q1 2022 and held it in 5 quarters.
  • UBS O'Connor's BELLUS Health Inc. position peaked at $2.77M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.